Solesence, Inc. Common Stock (SLSN)
Official siteCONSUMER DEFENSIVE • HOUSEHOLD & PERSONAL PRODUCTS • NASDAQ
Market Cap: $107.38M
Last updated: Nov 17, 2026 at 11:05 AM ET
Solesence, Inc. Common Stock (SLSN) Financials: Revenue, Profit and Cash Flow
Solesence, Inc. Common Stock reported revenue of $62.06M for the fiscal year ended Dec 31, 2025, up 18.6% from the year before. That year, net income was $2.81M with a net margin of 4.5%, operating cash flow was -$8.57M and free cash flow was -$10.71M. The quarter ended Sep 30, 2026 had revenue of $20.16M and net income of $3.67M.
Revenue and Margins
The operating margin was 4.2% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $10.78M, a compound annual rate of 21.5%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $62.06M | +18.6% | 27.5% | 4.2% | 4.5% |
| Dec 2024 | $52.35M | +40.4% | 24.9% | 3.8% | 2.1% |
| Dec 2023 | $37.30M | -0.1% | 19.5% | -11.0% | -13.2% |
| Dec 2022 | $37.32M | +26.6% | 22.4% | -6.1% | -7.0% |
| Dec 2021 | $29.48M | +72.1% | 29.5% | 8.7% | 7.9% |
| Dec 2020 | $17.12M | +36.9% | 35.0% | 8.7% | 5.8% |
| Dec 2019 | $12.51M | -11.9% | 20.9% | -22.4% | -24.0% |
| Dec 2018 | $14.19M | -18.0% | 23.2% | -14.3% | -14.7% |
| Dec 2017 | $17.32M | +60.6% | 22.2% | -4.5% | -4.6% |
| Dec 2016 | $10.78M | N/A | 30.0% | -11.8% | -11.9% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 155.5% from the year before. In the quarter ended Sep 2026, net income turned positive after a loss in the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $62.06M | $52.35M | $37.30M | $37.32M | $29.48M | $17.12M | $12.51M | $14.19M | $17.32M | $10.78M |
| Cost of revenue | $44.98M | $39.30M | $30.02M | $28.96M | $20.79M | $11.13M | $9.89M | $10.90M | $8.62M | $7.54M |
| Gross profit | $17.08M | $13.05M | $7.28M | $8.36M | $8.69M | $5.99M | $2.62M | $3.29M | $3.85M | $3.24M |
| Research and development | $4.09M | $3.84M | $3.84M | $3.04M | $2.23M | $1.57M | $1.87M | $2.06M | $1.74M | $1.55M |
| Operating income | $2.59M | $2.00M | -$4.09M | -$2.26M | $2.56M | $1.49M | -$2.80M | -$2.02M | -$772.00K | -$1.27M |
| Net income | $2.81M | $1.10M | -$4.94M | -$2.62M | $2.32M | $989.00K | -$3.01M | -$2.08M | -$789.00K | -$1.28M |
| EBITDA | $4.71M | $2.92M | -$3.35M | -$1.69M | $4.87M | $2.11M | -$2.45M | -$1.70M | -$411.00K | -$658.00K |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $20.16M | $15.33M | $12.96M | $12.48M | $14.60M | $20.36M | $14.63M | $12.57M | $16.87M | $13.05M | $9.87M | $8.01M |
| Gross profit | $7.93M | $4.65M | $3.17M | $3.43M | $3.47M | $6.53M | $3.53M | $2.77M | $5.78M | $3.74M | $3.58M | $471.00K |
| Operating income | $4.04M | $23.00K | -$674.00K | $187.00K | -$677.00K | $2.56M | $407.00K | -$224.00K | $2.87M | $1.05M | $1.11M | -$1.90M |
| Net income | $3.67M | -$256.00K | -$936.00K | $163.00K | -$1.02M | $3.32M | $231.00K | -$559.00K | $2.72M | $856.00K | $893.00K | -$2.13M |
Balance Sheet
As of Dec 2025, total debt of $11.76M exceeded cash and equivalents by $10.47M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $46.42M | $45.35M | $31.37M | $33.56M | $28.39M | $13.54M | $9.37M | $6.57M | $6.27M | $4.84M |
| Current assets | $25.14M | $24.70M | $14.79M | $16.63M | $11.60M | $8.84M | $4.99M | $4.69M | $4.62M | $3.43M |
| Cash and equivalents | $1.29M | $1.41M | $1.72M | $2.19M | $657.00K | $957.00K | $1.19M | $1.34M | $1.96M | $1.78M |
| Total liabilities | $32.42M | $35.06M | $30.98M | $27.91M | $20.93M | $10.81M | $7.86M | $5.18M | $3.03M | $2.05M |
| Short-term debt | $1.25M | $2.26M | $4.81M | $4.28M | $1.35M | $1.00M | $1.00M | $218.00K | $443.00K | $107.00K |
| Long-term debt | $10.50M | $0 | $6.00M | $4.00M | $1.00M | $952.00K | $0 | N/A | N/A | N/A |
| Shareholder equity | $14.00M | $10.29M | $387.00K | $5.65M | $7.46M | $2.73M | $1.51M | $1.38M | $3.23M | $2.79M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $44.44M | $46.28M | $43.99M | $50.05M | $50.24M | $59.96M | $57.02M | $50.00M | $48.05M | $40.85M | $38.50M | $32.88M |
| Total liabilities | $27.69M | $33.28M | $30.83M | $32.42M | $36.76M | $41.77M | $41.86M | $35.06M | $32.88M | $28.93M | $27.55M | $30.98M |
| Cash and equivalents | $1.27M | $1.05M | $573.00K | $1.29M | $429.00K | $4.11M | $1.82M | $1.41M | $2.92M | $2.36M | $2.02M | $1.72M |
| Shareholder equity | $16.75M | $13.00M | $13.16M | $17.63M | $13.48M | $18.19M | $15.16M | $14.95M | $15.17M | $11.92M | $4.95M | $1.90M |
Cash Flow
Operating cash flow was negative in the fiscal year ended Dec 2025.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$8.57M | $1.97M | -$2.01M | -$1.65M | $2.32M | -$2.06M | -$2.78M | -$1.34M | -$960.00K | -$241.00K |
| Capital expenditures | $2.14M | $4.56M | $1.05M | $2.82M | $1.87M | $878.00K | $740.00K | $160.00K | $209.00K | $165.00K |
| Free cash flow | -$10.71M | -$2.59M | -$3.06M | -$4.47M | $447.00K | -$2.94M | -$3.52M | -$1.50M | -$1.17M | -$406.00K |
| Investing cash flow | -$2.14M | -$4.56M | -$1.05M | -$2.82M | -$1.87M | -$878.00K | -$740.00K | -$160.00K | -$72.00K | -$165.00K |
| Financing cash flow | $10.59M | $2.27M | $2.59M | $6.00M | -$747.00K | $2.70M | $3.37M | $892.00K | $1.21M | $910.00K |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $6.72M | $191.00K | $1.52M | $1.82M | -$2.51M | -$654.00K | -$7.22M | $2.19M | $4.20M | -$565.00K | -$3.85M | -$2.65M |
| Capital expenditures | $539.00K | $469.00K | $528.00K | $450.00K | $418.00K | $1.41M | $133.00K | $2.59M | $1.40M | $477.00K | $85.00K | $199.00K |
| Free cash flow | $6.18M | -$278.00K | $989.00K | $1.37M | -$2.93M | -$2.06M | -$7.35M | -$404.00K | $2.80M | -$1.04M | -$3.94M | -$2.85M |
Frequently Asked Questions About SLSN
What is Solesence, Inc. Common Stock's annual revenue?
Solesence, Inc. Common Stock reported revenue of $62.06M for the fiscal year ended Dec 31, 2025.
How fast is Solesence, Inc. Common Stock's revenue growing?
Revenue was up 18.6% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 18.5%.
Is Solesence, Inc. Common Stock profitable?
Yes. Solesence, Inc. Common Stock reported net income of $2.81M for the fiscal year ended Dec 31, 2025, with a net margin of 4.5%.
How much free cash flow does SLSN generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of -$8.57M minus capital expenditures of $2.14M produced free cash flow of -$10.71M.
How much debt does Solesence, Inc. Common Stock have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $10.50M, short-term debt of $1.25M and cash and equivalents of $1.29M.
SLSN pages: Overview, Earnings, Financials, Valuation, Competitors